Rigel Pharmaceuticals is a clinical-stage drug development company focused on the discovery and development of novel, small-molecule drugs for the treatment of inflammatory and autoimmune diseases, as well as muscle disorders. The company’s research focuses on intracellular signaling pathways and related targets that are critical to disease mechanisms. RIGL has formed strategic collaborations with large pharmaceutical partners to develop and market its product candidates. For more information, visit the company’s Web site: http://www.rigel.comm
Let us hear your thoughts below: